Detalhe da pesquisa
1.
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Lancet Child Adolesc Health
; 7(4): 269-279, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803632